Profusa, Inc.

Profusa, Inc. (Nasdaq: PFSA) is a digital health and medical technology company focused on implantable biosensor platforms designed for continuous, real-time biochemical monitoring within the body. The company went public through a SPAC merger, entering the listed market in the healthcare technology sector. Its March 2023 Form 8-K filing disclosed a material corporate event during a period in which many post-merger SPAC companies were navigating post-combination operational and financing milestones. Profusa's work centers on tissue-integrated sensors that track oxygen and other biomarkers, positioning the company at the intersection of medtech and digital diagnostics. For full filing details, ownership data, and deal history on PFSA, sign up for complete access at SpacDesk.